Impact of qualifying artery on the efficacy of stenting plus medical therapy versus medical therapy alone in patients with symptomatic intracranial stenosis: a post-hoc analysis of the CASSISS trial
暂无分享,去创建一个
L. Jiao | Bing-jie Zheng | Huaizhang Shi | Daming Wang | Yiling Cai | Yuchen Li | Tao Wang | Tianxiao Li | P. Gao | Yingkun He | Zhenwei Zhao | Wei Wu | Guangquan Zhang | Jingtao Qi | Zhi-yong Ji | Shancai Xu | Qiaowei Wu | Chunlei Wang | P. Wu | Jie Wang | W. He | Jinbiao Yao
[1] Tianxiao Li,et al. Comparison of drug-coated balloon with conventional balloon for angioplasty in symptomatic intracranial atherosclerotic stenosis , 2023, Journal of neurointerventional surgery.
[2] T. Krings,et al. Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial. , 2022, JAMA.
[3] F. Gao,et al. Comparison of Drug-Eluting Stent With Bare-Metal Stent in Patients With Symptomatic High-grade Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial. , 2022, JAMA neurology.
[4] L. Jiao,et al. Timing and Outcomes of Intracranial Stenting in the Post-SAMMPRIS Era: A Systematic Review , 2021, Frontiers in Neurology.
[5] A. Nizam,et al. Infarct recurrence in intracranial atherosclerosis: Results from the MyRIAD study. , 2020, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[6] F. Gao,et al. Risk of Recurrence of Symptomatic Intracranial Atherosclerosis in Posterior Circulation Seen to Be Higher Than That in Anterior Circulation in Long-Term Follow-Up , 2020, Frontiers in Neurology.
[7] Z. Miao,et al. Early versus delayed stenting for intracranial atherosclerotic artery stenosis with ischemic stroke , 2019, Journal of NeuroInterventional Surgery.
[8] Lei Zhang,et al. Risk factors for hyperperfusion-induced intracranial hemorrhage after carotid artery stenting in patients with symptomatic severe carotid stenosis evaluation , 2018, Journal of NeuroInterventional Surgery.
[9] Ka Lung Chan,et al. Sustaining cerebral perfusion in intracranial atherosclerotic stenosis: The roles of antegrade residual flow and leptomeningeal collateral flow , 2018, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] K. Berger,et al. Direct Mechanical Intervention Versus Bridging Therapy in Stroke Patients Eligible for Intravenous Thrombolysis: A Pooled Analysis of 2 Registries , 2017, Stroke.
[11] A. Alexandrov,et al. Percutaneous transluminal angioplasty and stenting for symptomatic intracranial arterial stenosis: a systematic review and meta-analysis , 2016, Therapeutic advances in neurological disorders.
[12] T. Turan,et al. Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial. , 2016, JAMA neurology.
[13] L. Jiao,et al. China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China , 2015, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.
[14] Huaizhang Shi,et al. Hyperperfusion Syndrome After Stenting for Intracranial Artery Stenosis , 2015, Cell Biochemistry and Biophysics.
[15] H. Kirshner,et al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. , 2015, JAMA.
[16] Mark D. Johnson,et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial , 2014, The Lancet.
[17] Z. Rumboldt,et al. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. , 2013, Neurosurgery.
[18] A. Abou-Chebl,et al. Intracranial stenting with Wingspan: still awaiting a safe landing. , 2011, Stroke.
[19] A. Kastrup,et al. A systematic review on outcome after stenting for intracranial atherosclerosis. , 2009, Stroke.
[20] L. Wong. Global Burden of Intracranial Atherosclerosis , 2006, International journal of stroke : official journal of the International Stroke Society.
[21] S. Kasner,et al. Predictors of Ischemic Stroke in the Territory of a Symptomatic Intracranial Arterial Stenosis , 2006, Circulation.
[22] H. A. Smith,et al. A standardized method for measuring intracranial arterial stenosis. , 2000, AJNR. American journal of neuroradiology.
[23] Wei Li,et al. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. , 1998, Stroke.
[24] H. Lutsep,et al. Hemodynamic Markers in the Anterior Circulation as Predictors of Recurrent Stroke in Patients With Intracranial Stenosis , 2018, Stroke.
[25] Joseph Kang,et al. Post hoc analyses: after the facts. , 2015, Transplantation.
[26] I. Linfante. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial , 2015 .
[27] V. Chair,et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.
[28] J. Arenillas. Intracranial atherosclerosis: current concepts. , 2011, Stroke.
[29] Patty A. Morneault,et al. DEPARTMENT OF , 2007 .
[30] A. U. Rickel,et al. Guidelines for Prevention, I , 1998 .